|
|
|
| Clinical characteristics and prognosis of splenic tumor |
| ZHU Wenxiang1 WU Xianghua1▲ QIN Ya2 |
1.Division Ⅰ, Department of Gastrointestine and Gland Surgery, the First Affiliated Hospital of Guangxi Medical University, Guangxi Zhuang Autonomous Region, Nanning 530000, China;
2.Department of General Surgery, People's Hospital of Hechi City, Guangxi Zhuang Autonomous Region, Hechi 547000, China |
|
|
|
Abstract Objective To analyse the clinical characteristics and prognosis of splenic tumor. Methods From January 2003 to June 2017, in the First Affiliated Hospital of Guangxi Medical University, the clinical data of 64 patients diagnosed splenic tumor were etrospectively analyzed and followed-up, the clinical characteristics, diagnose, therapy and prognosis were analyzed. Results Among 64 splenic tumors cases, 53 cases were benign tumors and 11 cases were malignant tumors. Malignant tumors contained 8 primary splenictumors cases and 3 metastatic splenic tumors cases. The benign tumors were given splenectomy, and malignant tumors were given splenectomy combined with adjuvant radiotherapy and chemotherapy. Thirty-five cases benign tumors were followed up, 33 cases had a good recovery. Four cases with primary malignant tumors were followed up, the longest follow-up case treated with splenectomy and chemotherapy had been alive 7 years until December 2017. One case with splenic metastatic tumors were followed up, the patient had been alive 2 years after surgery. Conclusion The splenic tumor has a low incidence, pathology is complex, CT and B-mode ultrasound are important imaging measures to diagnose splenic tumor. The benign splenic tumors have a better prognosis, but malignant ones have a poor prognosis. The main treatment for splenic tumor is surgery. Earlier diagnosed, radical operation and chemotherapy are important measures for primary splenic malignant tumors.
|
|
|
|
|
|
[1] Morgenstern L，Rosenberg J，Geller SA. Tumors of the spleen [J]. World J Surg，1985，9（3）：468-476.
[2] 李桂臣，陈旭春，成东华，等.原发性脾肿瘤的诊断与治疗[J].中国医科大学学报，2013，42（12）：1095-1098.
[3] 孙重波，张高嘉，王殿昌.脾脏肿瘤的诊断与治疗（附24例报告）[J].中国肿瘤临床，1993（8）：600-602.
[4] 徐振宇，金琳芳，石鑫，等.32例脾脏肿瘤临床病理及预后分析[J].现代肿瘤医学，2016，24（5）：793-795.
[5] Robertson F，Leander P，Ekberg O. Radiology of the spleen [J]. Eur Radiol，2001，11（1）：80-95.
[6] 孙程明，李广浩，张玉宝.脾肿瘤61例外科诊治体会[J].现代诊断与治疗，2016，27（8）：1462-1464.
[7] 黄跃南，郭欣，王夫景，等.脾肿瘤的诊治进展[J].世界华人消化杂志，2006，14（4）：429-433.
[8] 刘吉盛，吴国刚，刘显义，等.脾脏肿瘤的外科治疗现状[J].中国冶金工业医学杂志，2012，29（5）：519-520.
[9] 赵夏夏，卢卫华，王银，等.超声检查对脾占位性病变的诊断价值[J].西北国防医学杂志，2006，27（4）：304-304.
[10] 王黎明，李春伶，高永艳.超声造影在脾局灶性病变诊断中的应用[J].中国医学影像学杂志，2015，23（8）：635-637.
[11] 曹佳颖，张晖，王文平，等.超声造影和增强CT诊断脾实质性肿瘤的比较研究[J].肿瘤影像学，2015，24（1）：30-34.
[12] 赵立群.CT平扫及增强扫描对脾脏病变的诊断意义[J].中国临床研究，2013，26（8）：838-839.
[13] 魏然，李万湖，黄勇，等.肺癌脾转移瘤的MDCT诊断[J].中华肿瘤防治杂志，2014，21（23）：1922-1924.
[14] 陆永文，谢婷婷，王成林.脾脏肿瘤CT、MRI诊断[J].中国CT和MRI杂志，2015，13（4）：79-80，104.
[15] 田士峰，刘爱连，李烨，等.多模态磁共振成像对脾脏实性良恶性肿瘤鉴别诊断的价值[J].中国临床医学影像杂志，2014，25（11）：781-786.
[16] 程春，陈蕾，梁晓航，等.脾错构瘤（红髓型）的高场MRI表现与临床病理分析（附5例报告）[J].陕西医学杂志，2014，43（12）：1659-1660.
[17] Morita K，Numate K，Tanaka K，et al. Sonographically guided core-needle biopsy of focal splenic lesions：report of four cases [J]. J Clin Ultrasound，2000，28（8）：417-424.
[18] 石岚，邓磊，龙轶，等.细针穿刺活检在脾脏疾病中的应用[J].云南医药，2017，38（2）：140-141.
[19] Treutner KH，Truong S，Schumpelick V. Splenic cyst. Diagnosis，indications and choice of procedure [J]. Chirurg，1988，59（7）：478-481.
[20] 李福鹏，邱法波.脾脏血管瘤病人403例回顾性分析[J].齐鲁医学杂志，2015，30（5）：532-534.
[21] 叶敬旻，陈燕凌.原发性脾脏恶性淋巴瘤手术治疗26例临床分析[J].福建医科大学学报，2014，48（4）：277-278.
[22] 侯婕，赵瑛.脾血管肉瘤1例报道[J].中国医药科学，2014，4（8）：138-140.
[23] 曾建挺，王春梅，张艳林，等.完全腹腔镜下脾肿瘤切除术的临床体会[J].腹部外科，2017，30（1）：15-17.
[24] 别平，陈健.腹腔镜脾切除术[J].中华肝脏外科手术学电子杂志，2015，4（3）：142-145.
[25] Koshenkov VP，Németh ZH，Carter MS. Laparoscopic spl-enectomy：outcome and efficacy for massive and supramassive spleens [J]. Am J Surg，2012，203（4）：517.
[26] 于杰，梁萍，于晓玲，等.超声引导经皮微波消融脾肿瘤的疗效分析[J].南方医科大学学报，2015，35（3）：333-337. |
|
|
|
